Search Results - "Celen, M.K"

Hepatocellular carcinoma in a long-term sustained virological responder following pegylated-interferon plus ribavirin combination therapy for chronic hepatitis C by Gunal, E, Celen, M.K

Get full text

P0639 : Telbivudine versus tenofovir-based treatment optimisation strategy in HBeAg-negative chronic hepatitis B patients by Krastev, Z, Kotzev, I, Celen, M.K, McNeeley, D, Hamed, K

Get full text

A phase 3 study comparing tenofovir alafenamide to tenofovir disoproxil fumarate in patients with HBeAg-negative, chronic hepatitis B: efficacy and safety results at week 96 by Brunetto, M, Lim, Y.S, Gane, E, Seto, W.K, Osipenko, M, Ahn, S.H, Janssen, H.L, Shukla, A, Chuang, W.L, Trinh, H, Celen, M.K, Flaherty, J.F, Lau, A.H, Gaggar, A, Suri, V, Bhardwaj, N, Kim, K, Subramanian, G.M, Pan, C, Izumi, N, Marcellin, P, Chan, H, Buti, M

Get full text

O4 PROLONGED THERAPY OF HEPATITIS DELTA FOR 96 WEEKS WITH PEGYLATED-INTERFERON-α-2a PLUS TENOFOVIR OR PLACEBO DOES NOT PREVENT HDVRNA RELAPSE AFTER TREATMENT: THE HIDIT-2 STUDY by Wedemeyer, H, Yurdaydin, C, Ernst, S, Caruntu, F.A, Curescu, M.G, Yalcin, K, Akarca, U.S, Gürel, S, Zeuzem, S, Erhardt, A, Lüth, S, Papatheodoridis, G.V, Keskin, O, Port, K, Radu, M, Celen, M.K, Ildeman, R, Stift, J, Heidrich, B, Mederacke, I, Hardtke, S, Koch, A, Dienes, H.P, Manns, M.P

Get full text

PS-042 - A phase 3 study comparing tenofovir alafenamide to tenofovir disoproxil fumarate in patients with HBeAg-negative, chronic hepatitis B: efficacy and safety results at week 96 by Brunetto, M., Lim, Y.S., Gane, E., Seto, W.K., Osipenko, M., Ahn, S.H., Janssen, H.L., Shukla, A., Chuang, W.L., Trinh, H., Celen, M.K., Flaherty, J.F., Lau, A.H., Gaggar, A., Suri, V., Bhardwaj, N., Kim, K., Subramanian, G.M., Pan, C., Izumi, N., Marcellin, P., Chan, H., Buti, M.

Get full text